Size-dependent immunogenicity: Therapeutic and protective properties of nano-vaccines against tumors

Journal of Immunology

Volumn 173, Issue 5, 2004, Pages 3148-3154

  Fifis, Theodora ^a   Gamvrellis, Anita ^a   Crimeen Irwin, Blessing ^a   Pietersz, Geoffrey A ^a   Li, Jie ^a   Mottram, Patricia L ^a   McKenzie, Ian F C ^a   Plebanski, Magdalena ^a  

^a AUSTIN RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM POTASSIUM SULFATE; ANTIGEN; CORD FACTOR; GAMMA INTERFERON; NANOPARTICLE; PHOSPHORYL LIPID A; QUIL A; TUMOR VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; DRUG DESIGN; IMMUNIZATION; IMMUNOGENICITY; LYMPH NODE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS;

EID: 4344697146     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.5.3148     Document Type: Article

References (26)

1. Ada, G. 2001. Vaccines and vaccination. N. Engl. J. Med. 345:1042.
2. Brown, G. V. 1999. Progress in the development of malaria vaccines: context and constraints. Parassitologia 41:429.
3. Falo, L. D., Jr., M. Kovacsovics-Bankowski, K. Thompson, and K. L. Rock. 1995. Targeting antigen into the phagocytic pathway in vivo induces protective tumour immunity. Nat. Med. 1:649.
4. Gallucci, S., M. Lolkema, and P. Matzinger. 1999. Natural adjuvants: endogenous activators of dendritic cells. Nat. Med. 5:1249.
5. Allsopp, C. E., M. Plebanski, S. Gilbert, R. E. Sinden, S. Harris, G. Frankel, G. Dougan, C. Hioe, D. Nixon, E. Paoletti, et al. 1996. Comparison of numerous delivery systems for the induction of cytotoxic T lymphocytes by immunization. Eur. J. Immunol. 26:1951.
6. Plebanski, M., S. C. Gilbert, J. Schneider, C. M. Hannan, G. Layton, T. Blanchard, M. Becker, G. Smith, G. Butcher, R. E. Sinden, and A. V. Hill. 1998. Protection from Plasmodium berghei infection by priming and boosting T cells to a single class I-restricted epitope with recombinant carriers suitable for human use. Eur. J. Immunol. 28:4345.
7. + T cell effector mechanisms in resistance to infection. Annu. Rev. Immunol. 18:275.
8. Pietersz, G. A., W. Li, V. Popovski, J. A. Caruana, V. Apostolopoulos, and I. F. McKenzie. 1998. Parameters for using mannan-MUC1 fusion protein to induce cellular immunity. Cancer Immunol. Immunother. 45:321.
9. Yeh, K. Y., A. J. McAdam, B. A. Pulaski, N. Shastri, J. G. Frelinger, and E. M. Lord. 1998. IL-3 enhances both presentation of exogenous particulate antigen in association with class I major histocompatibility antigen and generation of primary tumor-specific cytolytic T lymphocytes. J. Immunol. 160:5773.
10. Moore, M. W., F. R. Carbone, and M. J. Bevan. 1988. Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell 54:777.
11. Daemen, T., L. Riezebos-Brilman, J. Bungener, B. Regt, B. Donjte, and J. Wilschut. 2003. Eradication of established HPV16-transformed tumors after immunization with recombinant Semliki Forest virus expessing a fusion protein of E6 and E7. Vaccine 21:1082.
12. Schoenberger, S. P., R. E. Toes, E. I. van der Voort, R. Offringa, and C. J. Melief. 1998. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 393:480.
13. Fifis, T., P. Moltram, V. Bugdunoska, J. Hanley, and M. Plebanski. Short peptide sequences containing MHC class I and/or class II epitopes linked to mono-particles induce strong immunity and protection against tumour challenge in mice. Vaccine In press.
14. Jeannin, P., T. Renno, L. Goetsch, I. Miconnet, J. P. Aubry, Y. Delneste, N. Herbault, T. Baussant, G. Magistrelli, C. Soulas, et al. 2000. OmpA targets dendritic cells, induces their maturation and delivers antigen into the MHC class I presentation pathway. Nat. Immunol. 1:502.
15. Reimann, J., and S. H. Kaufmann. 1997. Alternative antigen processing pathways in anti-infective immunity. Curr. Opin. Immunol. 9:462.
16. + cells neither enhance nor suppress antitumor CTL activity in a mouse tumor model. J. Immunol. 161:2421.
17. Berinstein, N. L. 2002. Carcinoembryonic antigen as a target for therapeutic anticancer vaccines: a review. J. Clin. Oncol. 20:2197.
18. Kruth, H. S., J. Chang, I. Ifrim, and W. Y. Zhang. 1999. Characterization of patocytosis: endocytosis into macrophage surface-connected compartments. Eur. J. Cell Biol. 78:91.
19. Raychaudhuri, S., and K. L. Rock. 1998. Fully mobilizing host defense: building better vaccines. Nat. Biotechnol. 16:1025.
20. Sjolander, A., D. Drane, E. Maraskovsky, J. P. Scheerlinck, A. Suhrbier, J. Tennent, and M. Pearse. 2001. Immune responses to ISCOM formulations in animal and primate models. Vaccine 19:2661.
21. Schirmbeck, R., L. Deml, K. Melber, H. Wolf, R. Wagner, and J. Reimann. 1995. Priming of class I-restricted cytotoxic T lymphocytes by vaccination with recombinant protein antigens. Vaccine 13:857.
22. O'Hagan, D. T., M. L. MacKichan, and M. Singh. 2001. Recent developments in adjuvants for vaccines against infectious diseases. Biomol. Eng. 18:69.
23. Houde, M., S. Bertholet, E. Gagnon, S. Brunet, G. Goyette, A. Laplante, M. F. Princiotta, P. Thibault, D. Sacks, and M. Desjardins. 2003. Phagosomes are competent organelles for antigen cross-presentation. Nature 425:402.
24. Shortman, K., and Y. J. Liu. 2002. Mouse and human dendritic cell subtypes. Nat. Rev. Immunol. 2:151.
25. Guermonprez, P., I. Valladeau, L. Zitvogel, C. Thery, and S. Amigorena. 2002. Antigen presentation and T cell stimulation by dendritic cells. Annu. Rev. Immunol. 20:621.
26. Kruth, H. S., W. Y. Zhang, S. I. Skarlatos, and F. F. Chao. 1999. Apolipoprotein B stimulates formation of monocyte-macrophage surface-connected compartments and mediates uptake of low density lipoprotein-derived liposomes into these compartments. J. Biol. Chem. 274:7495.